HP Pyruvate MRI in Cancers
NCT05697406
Summary
Many human diseases are characterized by their ability to alter existing metabolic pathways and interrupt cellular processes. Cancer exploits the Warburg effect and utilizes greater glucose than normal cells and within this process uses anaerobic respiration, leading to increased conversion of pyruvate to lactate. This can be exploited by hyperpolarized imaging. Hyperpolarized 13C MRI imaging is an approach that utilizes a stable isotope of Carbon (13C) linked to pyruvate. MRI spectroscopy is used in conjunction with hyperpolarized 13C pyruvate in order to temporally detect pyruvate and its conversion to lactate in-vivo, in order to visualize downstream metabolic (glycolytic) activity secondary to the Warburg effect, which should be useful in detecting and characterizing tumors of various types. Hyperpolarized 13C pyruvate MR imaging has not been tested in most cancers. In this preliminary survey, we will test the hypothesis that hyperpolarized 13C pyruvate MR imaging can be used to image various cancers.
Eligibility
Inclusion Criteria: Clinical tumor diagnosis Patients with pre-existing MR imaging appointments Must be able to undergo MR Exclusion Criteria: No tumor diagnosis
Conditions4
Interventions1
Locations1 site
Find trials near these locations
Related trials
- Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body — National Heart Centre Singapore
- Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS) — Sunnybrook Health Sciences Centre
- Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors — Robert Bok, MD, PhD
- Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer — University of California, San Francisco
- Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors — University of California, San Francisco
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer — Ivan de Kouchkovsky, MD
- Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas — University of Maryland, Baltimore
- Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging — University of Maryland, Baltimore
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05697406